BioStacks

Supplement

Genistein/Daidzein Extract

Evidence

Moderate
Evidence: 3 of 5 (Moderate)

What the evidence says

Soy isoflavones (primarily genistein and daidzein) are phytoestrogens studied for menopausal vasomotor symptoms and bone density. Meta-analyses show a modest reduction in hot-flash frequency/severity vs. placebo; effects on bone density are smaller and less consistent.

Meta-analyses support modest reduction in menopausal hot flashes; bone-health evidence is weaker and mixed.

Top Genistein/Daidzein Extract supplements

About Genistein/Daidzein Extract

Soy isoflavones (primarily genistein and daidzein) are phytoestrogens studied for menopausal vasomotor symptoms and bone density. Meta-analyses show a modest reduction in hot-flash frequency/severity vs. placebo; effects on bone density are smaller and less consistent. Distinct from soy protein (see soy_protein) — isoflavones are the estrogenic component, not the macronutrient. Caution for individuals with estrogen-sensitive cancers without medical guidance.

What Genistein/Daidzein Extract supports

  • Moderate evidence for reducing menopausal hot-flash frequency and severity
  • Some evidence for supporting bone density in postmenopausal women — smaller, less consistent effect

How much Genistein/Daidzein Extract to take

The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.

Effective

40100

mg

Range used in menopausal-symptom and bone-density RCTs/meta-analyses (isoflavone aglycone equivalents).

Clinical evidence

Moderate clinical evidence. Meta-analyses support modest reduction in menopausal hot flashes; bone-health evidence is weaker and mixed.

Examine.com